In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
1 week 6 days ago
2 weeks 6 days ago
11 weeks 3 days ago
35 weeks 1 day ago
50 weeks 9 hours ago
1 year 6 weeks ago
1 year 6 weeks ago
1 year 7 weeks ago
1 year 12 weeks ago
1 year 13 weeks ago